INSM Dec 2025 62.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:34AM EDT. Market open.
Loading interactive chart...
- Zacks
Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire
Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its third-quarter 2024 financial results on Thursday, October 31, 2024.
- GuruFocus.com
Insmed Inc (INSM) Q2 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Insmed Inc (INSM) reports robust financial performance and outlines strategic initiatives for upcoming product launches amid competitive challenges.
© 2024 Yahoo. All rights reserved.